The short version
4 companies supply this market — a reasonable cushion if one runs into trouble.
Market view
ustekinumab-ttwe
15 marketed package NDCs · 4 active manufacturers
Most dispensed: USTEKINUMAB 45 mg/.5mL · Injection, Solution · #1 syringe/carton / .5 ml in 1 syringe · USTEKINUMAB 90 mg/mL · Injection, Solution · #1 syringe/carton / 1 ml in 1 syringe
Same drug class
Other molecules FDA puts in Interleukin-23 Antagonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Common questions
- Is Ustekinumab-ttwe in shortage right now?
- No. FDA does not currently list Ustekinumab-ttwe in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Ustekinumab-ttwe?
- 4 companies have marketed Ustekinumab-ttwe in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.